VRTX
Vertex Pharmaceuticals Inc
BIOTECHNOLOGY · HEALTHCARE
Vertex Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development of innovative therapies for serious diseases, primarily cystic fibrosis (CF). Renowned for its pioneering work in CF treatments, Vertex has made significant stri...
$553.15
-1.03% ($5.73)
Volume
3.21M
52W High
$568.67
52W Low
$403.16
Market Cap
$141.65B
Next Earnings Report
Last Reported
Nov 2, 2026 Missed
Actual: $4.22
vs. Consensus: $4.36
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q3 2026
Nov 2, 2026
1-Day:
-4.05%
Q2 2026
Aug 3, 2026
1-Day:
+1.70%
Q1 2026
May 5, 2026
1-Day:
+0.78%
Q1 2026
May 4, 2026
1-Day:
-1.28%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $3.33B | +12.5% | 85.3% | 37.4% | $1.10B |
| Q1'26 | $2.99B | +7.8% | 86.9% | 38.1% | $1.03B |
| Q4'25 | $3.23B | +10.8% | 85.6% | 40.3% | $1.19B |
| Q3'25 | $3.08B | +11.0% | 86.5% | 38.6% | $1.08B |
| Q2'25 | $2.96B | +12.1% | 86.3% | 38.8% | $1.03B |
| Q1'25 | $2.77B | +3.1% | 86.9% | 22.8% | $646.3M |
| Q4'24 | $2.91B | +15.7% | 85.5% | 35.2% | $913.0M |
| Q3'24 | $2.77B | +11.6% | 85.8% | 40.3% | $1.05B |
Company Information
Symbol
VRTX
Company
Vertex Pharmaceuticals Inc
Market Cap
$141.65B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare VRTX with competitors
Side-by-side earnings comparison